Atlas Trials

Cetuximab-IRDye 800CW and Intraoperative Imaging in Finding Pancreatic Cancer in Patients Undergoing Surgery

Clinical trial NCT02736578 · TERMINATED

Trial details

NCT number
NCT02736578
Sponsor
Eben Rosenthal
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2016-07-01
Primary completion
2017-04-24
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.